In 2011, PetSafe® brand launched its nationwide Bark for Your Park program to help communities build their own off-leash dog parks. In order to help even more communities this year, PetSafe brand is restructuring the contest into a grant-giving program and increasing the number of awards from five to 25.
“In the past five years, we’ve given away over $850,000 to communities to build dog parks of their own, but now we want to help communities during every stage of development,” said Tracy Mulder, marketing manager, PetSafe brand. “Our new Bark for Your Park program is expanding to not only help break ground on new parks, but also help fund maintenance and improvements for existing parks.”
Communities can submit a grant application now through June 30, 2016 on www.petsafe.net/barkforyourpark. The applications will be reviewed by an internal committee and PetSafe brand will award five new park grants valuing $25,000 each, 10 park makeover grants valuing $10,000 each, and 10 park maintenance grants valuing $5,000 each. This year’s award recipients will receive a combination of funds and commercial-grade dog park equipment from UltraSite, a PlayCore Company. The winning communities will be announced over a 5-week period during August through September.
To view the multimedia release go to:
http://www.multivu.com/players/English/7827752-petsafe-dogs-bark-for-your-park/
Oura Health, the Finnish health technology company behind the Oura ring, has moved its total private funding to 12.5M€ after the closure of a round led by US-based Bold Capital Partners and Finland’s Tesi. The funding will be used to scale US market operations and push the Oura platform forward.
The Oura ring and app guides wearers towards better sleep, recovery and readiness to perform by analyzing the body’s sleep, activity levels, daily rhythms and physiological responses.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8362451-oura-health-strengthens-position-us-market/
Although the NHS is ranked as one of the institutions that makes people ‘most proud to be British’1, a new poll commissioned by Astellas Pharma Europe Ltd, highlights that 91% of people feel that the health service is in need of change2. In particular, shorter waiting times (36% of respondents) and improved access to medicines (30%) rank most highly as the areas in need of greatest reform.
With only 1 in 4 of respondents agreeing that the Government currently spends enough on health, the survey reveals that those polled would be willing to accept an average charge of £10 for a missed GP appointment in order to improve service levels. The people polled also said they would be willing to pay an average of £170 per year in additional income tax for healthcare funding – which could result in approximately £5 billion in additional tax revenue for the Treasury3. In addition to these charges, 39% of those polled would be willing to accept an additional charge if it meant quicker access to healthcare services and 44% of those polled would be willing to accept additional charges if it meant access to newer and potentially more effective medicines.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7753151-astellas-survey-public-support-nhs-concern/
The Häagen-Dazs brand is helping to change the way ingredients are grown to better support bee populations by working hand-in-hand with its farmer suppliers. The internationally-recognized ice cream brand has installed one of the largest, privately funded pollinator habitats on the farmland of its almond supplier in California’s Central Valley. No stranger to helping the bees, the brand aims to impact additional ingredients used throughout its super-premium ice cream portfolio and positively influence sustainable agriculture practices.
The “Häagen-Dazs Loves Honey Bees” program launched in 2008, and today is expanding from research and educational funding to hands-on initiatives that will rejuvenate pollinator habitats to allow native bees to flourish. Located in Chowchilla, California, the habitat consists of six and a half miles of hedgerow and 11,000 native drought-tolerant shrubs and flowering plants, impacting 840 acres of farmland. In order to supply what pollinators need, the Häagen-Dazs brand worked with expert agronomists and the Xerces Society to maximize the impact of the habitat by choosing regional plants that are attractive to pollinators. Looking forward, the team will work to create custom habitats for more of its ingredient suppliers who depend on bees to pollinate their crops.
To view the multimedia release go to:
https://www.multivu.com/players/English/8075051-haagen-dazs-sustainable-agriculture-bees-pollinator-habitats/
Having lost his mother to the disease, singer, songwriter Gavin DeGraw knows firsthand how devastating pancreatic cancer is for patients and their families. Gavin is turning his grief into action by helping the Lustgarten Foundation raise awareness by encouraging people to get involved with the Foundation.
“My mother didn’t make it and unfortunately right now that’s a common story. But it doesn’t have to be the story permanently,” DeGraw said. “By funding research, the Lustgarten Foundation is going to change the course of this disease. I encourage everyone to get involved in some way – join a walk or make a donation.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213753-lustgarten-foundation-pancreatic-cancer-awareness/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Neighbors across the country will soon have an exciting opportunity to help change their communities for the better through State Farm Neighborhood Assist®. This philanthropic program awards 40 causes a $25,000 grant. Anyone in the United States can submit a cause beginning March 9 through March 30. Ultimately, voters will decide which community improvement projects win big.
Returning for its fourth year, State Farm Neighborhood Assist asks individuals to identify causes that would help make their communities safer, stronger and better-educated. Up to 4,000 causes will be accepted. The State Farm Youth Advisory Board (YAB) will then narrow down the field, using a scoring rubric to identify the top 200 submissions. The public will have a chance to vote 10 times a day from May 14 through June 3 for their favorite causes from the list of finalists. The 40 causes that receive the most votes will win a $25,000 grant. The nominations and votes will be accepted exclusively through a free Facebook app.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7417331-state-farm-neighborhood-assist/
CVS Health, the nation’s largest pharmacy innovation company, today launched an in-store fundraising campaign at CVS Pharmacy locations nationwide to benefit the American Lung Association’s LUNG FORCE initiative which aims to make lung cancer, the leading cancer killer of women in the United States, a public health priority.
Now through June 11, customers can donate $1, $3 or more at the register at 7,900 CVS Pharmacy locations and online at www.cvs.com/lung (all proceeds will support the initiative). CVS Health is the national presenting sponsor of LUNG FORCE, which is focused on raising awareness about lung cancer in women, and increasing research funding to save lives.
To view the multimedia release go to:
http://www.multivu.com/players/English/7817251-cvs-health-lung-force-fundraiser/
UWC International Patron, Shelby M.C. Davis and Anand Mahindra, Governor of UWC Mahindra College and Chairman of India’s Mahindra Group, today announced that together they will provide major new support for the UWC movement. Jointly, they are committing a total of US$12.5 million scholarship funding over the next five years.
Shelby Davis and Anand Mahindra said: “The world needs extraordinary leadership to navigate today’s complex challenges, tensions and conflicts, as well as to make the most of new opportunities. The UWC movement is ideally suited to provide such leaders and we are privileged to support it.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762531-Davis-Mahindra-scholarship/
Nuelle™, a sexual wellness and intimate care company focused on delivering groundbreaking solutions made specifically for women, announces today its Indiegogo campaign to raise awareness and funding for the company’s first product launch Fiera® Arouser for Her™.
In the US, roughly 46% of all American women, aged 18 – 70 have a sexual concern. Among committed couples, intimacy is important for both the health of the relationship and personal wellbeing. Sex, however, is often a tough subject to broach with partners, health care professionals and friends alike. Through its partnership with Indiegogo, Nuelle aims to normalize the conversation about women’s sexual wellbeing and the impact on quality of life, while educating couples about Fiera® Arouser for Her™ and its proven technology to scientifically enhance arousal and desire, naturally.
Co-created with women and healthcare professionals to bring back excitement to connect sexually with her partner, Nuelle’s Fiera® Arouser for Her™ is the first wearable intimacy enhancer used in advance of a sexual experience that is proven to ignite arousal and increase desire among women. In a study (after four weeks of using Fiera), 87% of women said they felt “in the mood” for sex and 83% enjoyed engaging in sex.*
To view the multimedia release go to:
http://www.multivu.com/players/English/7750851-nuelle-indiegogo-fiera-arouser-for-her/
Vanderbilt Mortgage and Finance, Inc., a Berkshire Hathaway company, has implemented an internal customer satisfaction scoring system aimed at measuring the overall experience of its home loan origination process.
The internal customer satisfaction score that Vanderbilt has created is a metric calculated from surveyed responses by customers within two weeks of funding their loan. The customers are asked to give a score ranging from zero to 10 on how likely they are to recommend Vanderbilt Mortgage to family and friends based on their home loan origination experience.
“We want to be transparent about the feedback we receive from our customers,” said Eric Hamilton, president of Vanderbilt Mortgage and Finance, Inc. “Continuously listening to customers’ needs in order to improve is our top priority. This scored system gives us a structured way to measure how we are doing and determine in which areas we can do better. It’s important for us to meet and exceed our customers’ expectations.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7716456-vanderbilt-mortgage-customer-survey/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
